BackFulcrum Therapeutics Overview

Fulcrum Therapeutics Current Cash

Latest current cash for FULC: $50M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$50.26M
19.16% YoYΔ $8.08M vs prior year quarter

Peer average

Loading

Fulcrum Therapeutics Current Cash History

Loading

Fulcrum Therapeutics vs. peers: Current Cash Comparison

Loading

Fulcrum Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Fulcrum Therapeutics (FULC) FAQ

As of the most recent data (March 2026), FULC shows a current cash of $50M. That compares with $42M in the prior-year period — up 19.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FULC's current cash is now $50M (was $42M) — a 19.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Fulcrum Therapeutics is outperforming or lagging.

Tracking FULC's current cash over time shows whether Fulcrum Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $50M That compares with $42M in the prior-year period — up 19.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Fulcrum Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $50M) with ownership activity and broader fundamentals.

Fulcrum Therapeutics's current cash is $50M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.